You are currently on the new version of our website. Access the old version .

277 Results Found

  • Article
  • Open Access
7 Citations
3,336 Views
9 Pages

A Sandwich ELISA for Quality Control of PCV2 Virus-like Particles Vaccine

  • Mingxia Sun,
  • Shanghui Wang,
  • Zheng Fang,
  • Man Zhao,
  • Yanfei Gao,
  • Tongqing An,
  • Yabin Tu,
  • Haiwei Wang and
  • Xuehui Cai

18 December 2022

Porcine circovirus type 2 (PCV2) is a highly prevalent virus in pig farms worldwide that causes significant economic losses in the swine industry. The PCV2 virus-like particles (VLPs) are potent subunit vaccines that are widely used. Currently, the a...

  • Article
  • Open Access
2,125 Views
9 Pages

Establishment of a Reference Material in Quality Control for Use in Infectivity and Identity Assays of Recombinant COVID-19 Vaccine, in Accordance with International Standards Organization Guidance

  • Ana Carolina Ferreira Ballestê Ajorio,
  • Michel Gomes Chagas,
  • Vinicius Pessanha Rhodes,
  • Anderson Peclat Rodrigues,
  • Natália Pedra Gonçalves,
  • Rodrigo Maciel da Costa Godinho,
  • Stephen James Forsythe,
  • Luciana Veloso da Costa and
  • Marcelo Luiz Lima Brandão

27 August 2024

The COVID-19 pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), began in 2019. One of the strategies for pandemic control was mass vaccination. In Brazil, the recombinant COVID-19 vaccine (RCV) was produced on a lar...

  • Article
  • Open Access
38 Citations
5,106 Views
16 Pages

The Importance of Quality Control of LSDV Live Attenuated Vaccines for Its Safe Application in the Field

  • Andy Haegeman,
  • Ilse De Leeuw,
  • Meruyert Saduakassova,
  • Willem Van Campe,
  • Laetitia Aerts,
  • Wannes Philips,
  • Akhmetzhan Sultanov,
  • Laurent Mostin and
  • Kris De Clercq

13 September 2021

Vaccination is an effective approach to prevent, control and eradicate diseases, including lumpy skin disease (LSD). One of the measures to address farmer hesitation to vaccinate is guaranteeing the quality of vaccine batches. The purpose of this stu...

  • Article
  • Open Access
1,146 Views
10 Pages

Novel Standard Substance from Primary Hamster Kidney Cells for Quality Control of Human Rabies Vaccines in China

  • Leitai Shi,
  • Jia Li,
  • Xiaohong Wu,
  • Shouchun Cao,
  • Yunpeng Wang,
  • Danhua Zhao and
  • Yuhua Li

13 February 2025

Background: Host cell proteins (HCPs) from primary hamster kidney cells (PHKCs) used to produce rabies vaccines may cause an allergic reaction in humans, so these residual HCPs must be controlled. Establishing a national standard for PHKC HCP is very...

  • Article
  • Open Access
3 Citations
1,610 Views
12 Pages

24 January 2025

Background/Objectives: An assay for protein content is essential but insufficient for quality control of acellular pertussis vaccines, which might consist of up to five components, each needing individual quantification. Generally, purified pertussis...

  • Article
  • Open Access
5 Citations
4,024 Views
9 Pages

Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production

  • Cao Li,
  • Guoxing Luo,
  • Yuanjun Zeng,
  • Feibo Song,
  • Han Yang,
  • Shiyin Zhang,
  • Yingbin Wang,
  • Tingdong Li,
  • Shengxiang Ge and
  • Ningshao Xia

5 February 2022

Non-replicating rotavirus vaccines are alternative strategies that may improve the protective efficacy of rotavirus vaccines in low- and middle-income countries. The truncated spike protein VP4 (aa26-476, VP4*)was a candidate antigen for the developm...

  • Review
  • Open Access
4 Citations
9,994 Views
23 Pages

Production Technologies, Regulatory Parameters, and Quality Control of Vaccine Vectors for Veterinary Use

  • Raquel de M. Barbosa,
  • Amélia M. Silva,
  • Classius F. da Silva,
  • Juliana C. Cardoso,
  • Patricia Severino,
  • Lyghia M. A. Meirelles,
  • Arnobio A. da Silva-Junior,
  • César Viseras,
  • Joel Fonseca and
  • Eliana B. Souto

This paper presents a comprehensive review of the main types of vaccines approaching production technology, regulatory parameters, and the quality control of vaccines. Bioinformatic tools and computational strategies have been used in the research an...

  • Article
  • Open Access
9 Citations
5,901 Views
16 Pages

Vaccine batches must pass routine quality control to confirm that their ability to induce protection against disease is consistent with batches of proven efficacy from development studies. For poultry vaccines, these tests are often performed in labo...

  • Article
  • Open Access
6 Citations
5,687 Views
13 Pages

Vaccine Production Process: How Much Does the General Population Know about This Topic? A Web-Based Survey

  • Angela Bechini,
  • Paolo Bonanni,
  • Beatrice Zanella,
  • Giulia Di Pisa,
  • Andrea Moscadelli,
  • Sonia Paoli,
  • Leonardo Ancillotti,
  • Benedetta Bonito and
  • Sara Boccalini

Background: Vaccine hesitancy has been recognized as a major global health threat by the World Health Organization. Many studies have investigated vaccine safety as a determinant for vaccine hesitancy; however, not much attention has been paid to vac...

  • Commentary
  • Open Access
2 Citations
3,061 Views
10 Pages

6 January 2023

Vaccine hesitancy is a considerable obstacle to achieving vaccine protection worldwide. There needs to be more evidence-based research for interventions for vaccine hesitancy. Existing effectiveness evaluations are limited to one particular hypothesi...

  • Article
  • Open Access
3 Citations
2,542 Views
11 Pages

Quantitation of Enterovirus A71 Empty and Full Particles by Sedimentation Velocity Analytical Ultracentrifugation

  • Anna Yang,
  • Yun Luo,
  • Jie Yang,
  • Tingbo Xie,
  • Wenhui Wang,
  • Xin Wan,
  • Kaiwen Wang,
  • Deqin Pang,
  • Dongsheng Yang and
  • Hanyu Dai
  • + 5 authors

8 April 2024

The enterovirus A71 (EV71) inactivated vaccine is an effective intervention to control the spread of the virus and prevent EV71-associated hand, foot, and mouth disease (HFMD). It is widely administered to infants and children in China. The empty par...

  • Review
  • Open Access
1 Citations
2,124 Views
17 Pages

Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines

  • Petr G. Lokhov,
  • Elena E. Balashova,
  • Oxana P. Trifonova,
  • Dmitry L. Maslov and
  • Alexander I. Archakov

In omics sciences, many compounds are measured simultaneously in a sample in a single run. Such analytical performance opens up prospects for improving cellular cancer vaccines and other cell-based immunotherapeutics. This article provides an overvie...

  • Article
  • Open Access
2 Citations
3,081 Views
17 Pages

Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine

  • Rosa Bartolomeo,
  • Fulvia Troise,
  • Simona Allocca,
  • Giulia Sdruscia,
  • Rosa Vitale,
  • Veronica Bignone,
  • Anna Maria Petrone,
  • Giuseppina Romano,
  • Anna Morena D’Alise and
  • Valentino Ruzza
  • + 8 authors

19 March 2024

Quality control testing of vaccines, including potency assessment, is critical to ensure equivalence of clinical lots. We developed a potency assay to support the clinical advancement of Nous-209, a cancer vaccine based on heterologous prime/boost ad...

  • Article
  • Open Access
8 Citations
2,330 Views
15 Pages

Controlling the Quality of Nanodrugs According to Their New Property—Radiothermal Emission

  • Gleb V. Petrov,
  • Daria A. Galkina,
  • Alena M. Koldina,
  • Tatiana V. Grebennikova,
  • Olesya V. Eliseeva,
  • Yana Yu. Chernoryzh,
  • Varvara V. Lebedeva and
  • Anton V. Syroeshkin

Previous studies have shown that complexly shaped nanoparticles (NPs) have their intrinsic radiothermal emission in the millimeter range. This article presents a method for controlling the quality of nanodrugs—immunobiological preparations (IBP...

  • Article
  • Open Access
30 Citations
12,234 Views
35 Pages

Biophysical Characterization of Viral and Lipid-Based Vectors for Vaccines and Therapeutics with Light Scattering and Calorimetric Techniques

  • Natalia Markova,
  • Stefan Cairns,
  • Hanna Jankevics-Jones,
  • Michael Kaszuba,
  • Fanny Caputo and
  • Jérémie Parot

30 December 2021

Novel vaccine platforms for delivery of nucleic acids based on viral and non-viral vectors, such as recombinant adeno associated viruses (rAAV) and lipid-based nanoparticles (LNPs), hold great promise. However, they pose significant manufacturing and...

  • Article
  • Open Access
1,741 Views
15 Pages

Vaccination Schedules Recommended by the Centers for Disease Control and Prevention: From Human-Readable to Machine-Processable

  • Xia Jing,
  • Hua Min,
  • Yang Gong,
  • Mytchell A. Ernst,
  • Aneesa Weaver,
  • Chloe Crozier,
  • David Robinson,
  • Dean F. Sittig,
  • Paul G. Biondich and
  • Samuil Orlioglu
  • + 9 authors

22 April 2025

Background: Reusable, machine-processable clinical decision support system (CDSS) rules have not been widely achieved in the medical informatics field. This study introduces the process, results, challenges faced, and lessons learned while converting...

  • Review
  • Open Access
9 Citations
5,586 Views
15 Pages

Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic Review

  • Cindra Tri Yuniar,
  • Bhekti Pratiwi,
  • Ardika Fajrul Ihsan,
  • Bambang Tri Laksono,
  • Iffa Risfayanti,
  • Annisa Fathadina,
  • Yeonseon Jeong and
  • Eunyoung Kim

17 February 2022

Background: Assessing the quality of evidence from vaccine clinical trials is essential to ensure the safety and efficacy of the vaccine and further enhance public acceptance. This study aims to summarize and critically evaluate the quality of harm r...

  • Article
  • Open Access
5 Citations
4,890 Views
13 Pages

Evaluation of Quality Control Methods for Foot-And-Mouth Disease Vaccines by High-Performance Liquid Chromatography

  • Mun-Hyeon Kim,
  • Seon-Jong Yun,
  • Yeon-Hee Kim,
  • Hyang-Sim Lee,
  • Ji-Yeon Kim,
  • Ji-Ye Kim,
  • JeongWoo Kang,
  • Yong-Sang Kim and
  • Min-Goo Seo

Foot-and-mouth disease (FMD) is considered one of the highly contagious viral infections affecting livestock. In Korea, an FMD vaccination policy has been implemented nationwide since 2010 for the prevention and control of FMD. Since the vaccines are...

  • Brief Report
  • Open Access
1 Citations
4,167 Views
15 Pages

Sixteen Years of HPV Vaccination in Mexico: Report of the Coverage, Procurement, and Program Performance (2008–2023)

  • Rodrigo Romero-Feregrino,
  • Raúl Romero-Cabello,
  • Raúl Romero-Feregrino,
  • Paulina Vilchis-Mora,
  • Berenice Muñoz-Cordero and
  • Mario Alfredo Rodríguez-León

Introduction: In 2008, Mexico initiated its national HPV vaccination program targeting adolescent girls. This study aims to evaluate the current status of the program, analyzing trends in vaccine acquisition, administration, and coverage over a 16-ye...

  • Article
  • Open Access
2,049 Views
22 Pages

Nineteen-Year Evidence on Measles–Mumps–Rubella Immunization in Mexico: Programmatic Lessons and Policy Implications

  • Rodrigo Romero-Feregrino,
  • Raul Romero-Feregrino,
  • Raul Romero-Cabello,
  • Berenice Muñoz-Cordero,
  • Benjamin Madrigal-Alonso and
  • Valeria Magali Rocha-Rocha

31 October 2025

Background: In Mexico, the measles vaccine was first introduced in 1971. The last case of measles acquired through endemic transmission was recorded in 1995. In 1998, the monovalent measles vaccine was replaced by the combined measles–mumps&nda...

  • Article
  • Open Access
3 Citations
6,572 Views
9 Pages

The Lean Six Sigma Define, Measure, Analyze, Implement, Control (LSS DMAIC) Framework: An Innovative Strategy for Quality Improvement of Pharmacist Vaccine Recommendations in Community Pharmacy

  • Kenneth C. Hohmeier,
  • Chelsea Renfro,
  • Benjamin Loomis,
  • Connor E. Alexander,
  • Urvi Patel,
  • Matthew Cheramie,
  • Alina Cernasev,
  • Tracy Hagemann,
  • Chi-Yang Chiu and
  • Marie A. Chisholm-Burns
  • + 1 author

22 April 2022

Community pharmacies represent a highly accessible and convenient setting for vaccination. However, setting-specific barriers exist which contribute to suboptimal vaccination rates, particularly for pneumococcal vaccinations. One proven quality impro...

  • Article
  • Open Access
7 Citations
4,718 Views
12 Pages

Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay

  • Thomas J. M. Michiels,
  • Wichard Tilstra,
  • Martin R. J. Hamzink,
  • Justin W. de Ridder,
  • Maarten Danial,
  • Hugo D. Meiring,
  • Gideon F. A. Kersten,
  • Wim Jiskoot and
  • Bernard Metz

1 December 2020

Currently, batch release of toxoid vaccines, such as diphtheria and tetanus toxoid, requires animal tests to confirm safety and immunogenicity. Efforts are being made to replace these tests with in vitro assays in a consistency approach. Limitations...

  • Article
  • Open Access
5 Citations
3,475 Views
11 Pages

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

  • Elena Pancisi,
  • Anna Maria Granato,
  • Emanuela Scarpi,
  • Laura Ridolfi,
  • Silvia Carloni,
  • Cinzia Moretti,
  • Massimo Guidoboni,
  • Francesco De Rosa,
  • Sara Pignatta and
  • Claudia Piccinini
  • + 8 authors

23 June 2022

Advanced therapy medical products (ATMPs) are rapidly growing as innovative medicines for the treatment of several diseases. Hence, the role of quality analytical tests to ensure consistent product safety and quality has become highly relevant. Sever...

  • Article
  • Open Access
2 Citations
3,778 Views
15 Pages

Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria

  • Khedidja Tahar djebbar,
  • Mounia Allouache,
  • Salim Kezzal,
  • Fouzia Benguerguoura,
  • Chafia TouilBoukoffa,
  • Ines Zidi,
  • Rachida Raache and
  • Hadda-Imene Ouzari

In Algeria, vaccination against pertussis is carried out using the whole-cell pertussis vaccine combined with the diphtheria and tetanus toxoids (DTwp). The quality control of vaccines locally produced or imported is carried out before the batch rele...

  • Article
  • Open Access
1 Citations
1,323 Views
16 Pages

Background/Objectives: Lawsonia intracellularis is a bacterium that causes Proliferative Enteropathy, an enteric infection characterized mainly by diarrhea and growth retardation, leading to important economic losses. Acute and chronic infections are...

  • Communication
  • Open Access
2 Citations
2,402 Views
8 Pages

Recombinant Factor C as an In Vitro Assay for the Residual Pathogenicity Evaluation of Veterinary Autogenous Vaccines

  • Antonella Di Paolo,
  • Rosario Liberti,
  • Lucia Anzalone,
  • Claudia Colabella,
  • Andrea Felici,
  • Giulio Severi and
  • Monica Cagiola

21 December 2024

Background: Veterinary autogenous vaccines, similar to all injectable pharmaceutical products, must be tested to assess endotoxin concentrations. The Limulus Amebocyte Lysate Test (LAL test) is widely used in in vitro quality control assays for endot...

  • Review
  • Open Access
1 Citations
2,812 Views
38 Pages

Animal-based tests are used for the control of vaccine quality. However, because highly purified and safe vaccines are now available, alternative approaches that can replace or reduce animal use for the assessment of vaccine outcomes must be establis...

  • Article
  • Open Access
11 Citations
4,403 Views
14 Pages

Effects of a Recombinant Gonadotropin-Releasing Hormone Vaccine on Reproductive Function in Adult Male ICR Mice

  • Ai-Mei Chang,
  • Chen-Chih Chen,
  • Ding-Liang Hou,
  • Guan-Ming Ke and
  • Jai-Wei Lee

Gonadotropin-releasing hormone (GnRH) regulates the reproductive endocrine system in mammals. The GnRH immunocontraception vaccine can aid animal population control and management. We evaluated a recombinant GnRH fusion protein with the adjuvant MONT...

  • Article
  • Open Access
14 Citations
3,253 Views
7 Pages

10 October 2019

Vaccination for foot-and-mouth (FMD) disease remains low in parts of Africa despite the existence of vaccines. In East Africa, the presence of multiple virus serotypes and sub-types makes matching a vaccine with the circulating virus type in the fiel...

  • Review
  • Open Access
14 Citations
7,705 Views
42 Pages

31 January 2024

To achieve the World Health Organization’s global Sustainable Development Goals, increased production of high-quality protein for human consumption is required while minimizing, ideally reducing, environmental impacts. One way to achieve these...

  • Article
  • Open Access
1,000 Views
19 Pages

13 August 2025

A new polypeptide vaccine towards salmon lice (Lepeophtheirus salmonis) was given to experimental groups of 2 × 8000 Atlantic salmon parr (Salmo salar L.), following the vaccination of a total of 4 × 8000 parr with a common set of vaccine...

  • Systematic Review
  • Open Access
5 Citations
4,392 Views
22 Pages

12 November 2021

Immunisation of livestock with high quality vaccines is considered an essential approach to controlling many animal diseases. The only currently available commercial vaccine to protect cattle from East Coast fever (ECF), a tick-borne disease caused b...

  • Review
  • Open Access
26 Citations
15,262 Views
21 Pages

Sustaining Vaccine Confidence in the 21st Century

  • Karin Hardt,
  • Ruprecht Schmidt-Ott,
  • Steffen Glismann,
  • Richard A. Adegbola and
  • François P. Meurice

24 June 2013

Vaccination provides many health and economic benefits to individuals and society, and public support for immunization programs is generally high. However, the benefits of vaccines are often not fully valued when public discussions on vaccine safety,...

  • Opinion
  • Open Access
2 Citations
4,264 Views
14 Pages

29 October 2024

During the COVID-19 pandemic, eight COVID-19 vaccines were authorised in the European Union (EU); as a result of emerging SARS-CoV-2 variants and waning immunity, some of these have been adapted to broaden the immunity against circulating variants. T...

  • Article
  • Open Access
80 Citations
26,756 Views
10 Pages

Development of mRNA Vaccines: Scientific and Regulatory Issues

  • Ivana Knezevic,
  • Margaret A. Liu,
  • Keith Peden,
  • Tiequn Zhou and
  • Hye-Na Kang

23 January 2021

The global research and development of mRNA vaccines have been prodigious over the past decade, and the work in this field has been stimulated by the urgent need for rapid development of vaccines in response to an emergent disease such as the current...

  • Commentary
  • Open Access
11 Citations
5,355 Views
9 Pages

Challenges in the Application of African Swine Fever Vaccines in Asia

  • Agathe Auer,
  • Giovanni Cattoli,
  • Pawin Padungtod,
  • Charles E. Lamien,
  • Yooni Oh,
  • Sarah Jayme and
  • Andriy Rozstalnyy

25 August 2024

This paper explores the significance of quality vaccines in managing ASF in Asia, where it poses a substantial threat to the pork industry. It emphasizes the risks associated with substandard vaccines, including the emergence of new virus strains tha...

  • Review
  • Open Access
7 Citations
4,151 Views
25 Pages

28 February 2025

Persistent infection of porcine reproductive and respiratory syndrome virus (PRRSV) significantly hampers both the quantity and quality of pork production in China. Although PRRSV is widely prevalent worldwide, the absence of effective vaccines has m...

  • Article
  • Open Access
12 Citations
9,723 Views
12 Pages

Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines

  • Xiaojuan Yu,
  • Chuanfei Yu,
  • Xiaohong Wu,
  • Yu Cui,
  • Xiaoda Liu,
  • Yan Jin,
  • Yuhua Li and
  • Lan Wang

Lipid nanoparticles (LNPs) are widely used as delivery systems for mRNA vaccines. The stability and bilayer fluidity of LNPs are determined by the properties and contents of the various lipids used in the formulation system, and the delivery efficien...

  • Article
  • Open Access
24 Citations
5,836 Views
8 Pages

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control

  • Marco Caminati,
  • Gabriella Guarnieri,
  • Veronica Batani,
  • Elena Scarpieri,
  • Anita Finocchiaro,
  • Fulvia Chieco-Bianchi,
  • Gianenrico Senna and
  • Andrea Vianello

4 August 2021

Background: COVID-19 vaccination has been recommended for severe asthmatics. We aimed to evaluate the safety, tolerability, and impact on disease control and patient’s quality of life of the mRNA SARS-CoV-2/COVID-19 vaccine in severe asthma patients...

  • Communication
  • Open Access
40 Citations
4,407 Views
6 Pages

14 September 2021

COVID-19 vaccine hesitancy has been a growing concern. The pandemic has proved to be very complicated with the mutated virus. The Delta variant is contributing to a surge of cases across the globe. Vaccine hesitancy can be socially contagious, requir...

  • Article
  • Open Access
430 Views
12 Pages

COVID-19 Vaccination Modifies COVID-19-Related Headache Phenotype: Evidence from Case–Control Study on 309 Participants

  • Henar Ruiz-Saez,
  • Ana Echavarría Íñiguez,
  • Yésica González Osorio,
  • Javier Trigo López,
  • Álvaro Sierra-Mencía,
  • Andrea Recio-García,
  • Álvaro Planchuelo-Gómez,
  • Ana González-Celestino,
  • María Luisa Hurtado and
  • Leticia Sierra
  • + 19 authors

27 November 2025

Background: Headache is a common symptom during acute viral infections, and its pathophysiology has been linked with the immune response to the virus. Headache is one of the most frequent symptoms of coronavirus disease 2019 (COVID-19), and it has be...

  • Article
  • Open Access
2 Citations
1,927 Views
15 Pages

Redox Balance and Inflammatory Response in Follicular Fluids of Women Recovered by SARS-CoV-2 Infection or Anti-COVID-19 Vaccinated: A Combined Metabolomics and Biochemical Study

  • Maria A. Castiglione Morelli,
  • Assunta Iuliano,
  • Licia Viggiani,
  • Ilenia Matera,
  • Alessandro Pistone,
  • Sergio C. A. Schettini,
  • Paola Colucci and
  • Angela Ostuni

To date, not many studies have presented evidence of SARS-CoV-2 infecting the female reproductive system. Furthermore, so far, no effect of the administration of anti-COVID 19 vaccines has been reported to affect the quality of oocytes retrieved from...

  • Systematic Review
  • Open Access
4 Citations
3,315 Views
15 Pages

COVID-19 Vaccines and Assisted Reproductive Techniques: A Systematic Review

  • Elena Satorres-Pérez,
  • Alicia Martínez-Varea and
  • José Morales-Roselló

4 August 2023

Objective: To review the current knowledge concerning COVID-19 vaccination and assisted reproductive techniques (ART). Methods: A systematic review in Pubmed-Medline, the Cochrane Database, the Web of Science, and the National Guideline was performed...

  • Article
  • Open Access
12 Citations
4,148 Views
12 Pages

Efficacy of a Turkey Herpesvirus Vectored Newcastle Disease Vaccine against Genotype VII.1.1 Virus: Challenge Route Affects Shedding Pattern

  • Vilmos Palya,
  • Tímea Tatár-Kis,
  • Abdel Satar A. Arafa,
  • Balázs Felföldi,
  • Tamás Mató and
  • Ahmed Setta

11 January 2021

The control of Newcastle disease (ND) highly relies on vaccination. Immunity provided by a ND vaccine can be characterized by measuring the level of clinical protection and reduction in challenge virus shedding. The extent of shedding depends a lot o...

  • Article
  • Open Access
6 Citations
7,527 Views
23 Pages

Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program

  • Mikhail Tarasov,
  • Andrei Shanko,
  • Larisa Kordyukova and
  • Anton Katlinski

30 August 2020

Background: today’s standard quality control methods used to control the protein composition of inactivated influenza vaccines only take into account a few key reference components. They do not allow for thorough characterization of protein com...

  • Review
  • Open Access
132 Citations
15,414 Views
22 Pages

Review: Vaccines and Vaccination against Lumpy Skin Disease

  • Eeva Tuppurainen,
  • Klaas Dietze,
  • Janika Wolff,
  • Hannes Bergmann,
  • Daniel Beltran-Alcrudo,
  • Anna Fahrion,
  • Charles Euloge Lamien,
  • Frank Busch,
  • Carola Sauter-Louis and
  • Franz J. Conraths
  • + 3 authors

6 October 2021

The geographical distribution of lumpy skin disease (LSD), an economically important cattle disease caused by a capripoxvirus, has reached an unprecedented extent. Vaccination is the only way to prevent the spread of the infection in endemic and newl...

  • Perspective
  • Open Access
3 Citations
5,025 Views
11 Pages

Why Foot-and-Mouth Disease-Free with Vaccination Should Be Equivalent to Foot-and-Mouth Disease-Free without Vaccination

  • Pedro Moura,
  • Ulrich Kihm,
  • Alejandro Schudel,
  • Ingrid Bergmann and
  • Patrik Buholzer

19 June 2024

Foot-and-Mouth Disease (FMD) is still one of the most relevant animal diseases and remains of global concern. The World Organization for Animal Health (WOAH) has specified two sanitary statuses that assure freedom from FMD: a country or zone can be f...

  • Article
  • Open Access
5 Citations
3,583 Views
15 Pages

Quality and Safety of Vaccines Manufacturing: An Online Survey on Attitudes and Perceptions of Italian Internet Users

  • Angela Bechini,
  • Beatrice Zanella,
  • Benedetta Bonito,
  • Sonia Paoli,
  • Giulia Di Pisa,
  • Andrea Moscadelli,
  • Leonardo Ancillotti,
  • Paolo Bonanni and
  • Sara Boccalini

13 September 2021

Background: Vaccination is a worldwide public health practice that requires high uptake levels in order to effectively reduce the incidence of vaccine-preventable diseases. The manufacturing of vaccines is a complex process, and little is known about...

  • Review
  • Open Access
6 Citations
4,256 Views
16 Pages

30-Year Development of Inactivated Virus Vaccine in China

  • Jinrong Shi,
  • Ailin Shen,
  • Yao Cheng,
  • Chi Zhang and
  • Xiaoming Yang

Inactivated vaccines are vaccines made from inactivated pathogens, typically achieved by using chemical or physical methods to destroy the virus’s ability to replicate. This type of vaccine can induce the immune system to produce an immune resp...

  • Article
  • Open Access
20 Citations
5,213 Views
17 Pages

Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use

  • Barbara Bolgiano,
  • Eilís Moran,
  • Nicola J. Beresford,
  • Fang Gao,
  • Rory Care,
  • Trusha Desai,
  • Ida Karin Nordgren,
  • Timothy R. Rudd,
  • Ian M. Feavers and
  • Prashant Bore
  • + 16 authors

Towards achieving the goal of eliminating epidemic outbreaks of meningococcal disease in the African meningitis belt, a pentavalent glycoconjugate vaccine (NmCV-5) has been developed to protect against Neisseria meningitidis serogroups A, C, Y, W and...

of 6